___

• Antithrombotic Trialists’ Collaboration, 2002. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. B.M.J. 324, 71-86.
• Califf, R.M., Mark, D.B., Harrell, F.E., Jr Hlatky, M.A., Lee, K.L., Rosati, R.A., Pryor, D.B., 1988. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. J. Am. Coll. Cardiol. 11, 20-26.
• C.A.P.R.I.E. Steering Committee, 1996. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (C.A.P.R.I.E.). Lancet. 348, 1329-1339.
• Cox, J., Naylor, C.D., 1992. The Canadian Cardiovascular Society grading scale for angina pectoris: Is it time for refinements. Ann. Intern. Med. 117, 677-683.
• Diamond, A.G., 1983. A clinically relevant classification of chest discomfort. J. Am. Coll. Cardiol. 1, 574–575.
• Emond, M., Mock, M.B., Davis, K.B., Fisher, L.D., Holmes, D.R., Jr Chaitman, B.R., Kaiser, G.C., Alderman, E., Killip, T., 1994. III. Long-term survival of medically treated patients in the coronary artery surgery study (C.A.S.S.) registry. Circulation. 90, 2645-2657.
• ESC/EAS Guidelines for the management of dyslipidaemias, 2011. Eur. Heart J. 32, 1769–1818.
• European Society of Cardiology, 2006. Guidelines on the management of stable angina pectoris. Eur. Heart J. 27, 1341-1381.
• European Society of Cardiology and the European Association for Cardio-Thoracic Surgery Guidelines on myocardial revascularization, 2010. Eur. Heart J. 31, 2501-2555.
• European Society of Hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension. Eur. Heart J. 28, 1462-1536.
• Fox, K., Ford, I., Steg, P.G., Tendera, M., Robertson, M., Ferrari, R., 2009. Beautiful investigators. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: A subgroup analysis of the randomized, controlled beautiful trial. Eur. Heart J. 30, 2337-2345.
• Fox, M.K., 2003. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 362, 782-788.
• Fu, L.W., Longhurst, J.C., 2005. Interactions between histamine and bradykinin in stimulation of ischaemically sensitive cardiac afferents in felines. J. Physiol. 565, 1007.
• Hultgren, H.N., Peduzzi, P., 1984. Relation of severity of symptoms to prognosis in stable angina pectoris. Am. J. Cardiol. 54, 988-993.
• Mark, D.B., Hlatky, M.A., Harrell, F.E., Jr Lee, K.L., Califf, R.M., Pryor, D.B., 1987. Exercise treadmill score for predicting prognosis in coro- nary artery disease. Ann. Intern. Med. 106, 793-800.
• Marzilli, M., Klein, W.W., 2003. Efficacy and tolerability of trimetazidine in stable angina: A meta-analysis of randomized, double-blind, con- trolled trials. Coron. Artery Dis. 14, 171–179.
• Nissen, S.E., Tuzcu, E.M., Libby, P., Thompson, P.D., Ghali, M., Garza, D., Berman, L., Shi, H., Buebendorf, E., Topol, E.J., 2004. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: The camelot study: A randomized controlled trial. JAMA. 292, 2217-2225.
• Onat, A., Şurdum-Avcı, G., Şenocak, M., Örnek, E.,Gözükara, Y., Karaaslan, Y., Özışık, U., İşler, M., Tabak, F., Özcan, R., 1991. Türkiye'de erişkinlerde kalp hastalığı ve risk faktörleri sıklığı taraması: 3. Kalp hastalıkları prevalansı. Türk Kardiyol. Dern. Arş. 19, 26-33.
• Raab, W., 1962. The sympathogenic biochemical trigger mechanism of angina pectoris: Its therapeutic suppression and long-term prevention. Am. J. Cardiol. 9, 576-590.
• The Danish verapamil infarction trial II–DAVIT II, 1990. Effect of verapamil on mortality and major events after acute myocardial infarction. Am. J. Cardiol. 66, 779-785.
• The multicenter diltiazem postinfarction trial research group-MDPIT. 1988. The effect of diltiazem on mortality and reinfarction after myocar- dial infarction. N. Engl. J. Med. 319, 385-392.
• Werdan, K., Ebelt, H., Nuding, S., Höpfner, F., Hack, G., Müller-Werdan, U., 2012. Ivabradine in combination with beta-blocker improve symptoms and quality of life in patients with stable angina pectoris: Results from the ADDITIONS study. Clin. Res. Cardiol. 101, 365-373.
• Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., Dagenais, G., 2000. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N. Engl. J. Med. 342, 145-153.